Balanced expression of single subunits in a multisubunit protein, achieved by cell fusion of individual transfectants Lars Norderhaug1, Finn-Eirik Johansen2and Inger Sandlie3 1 Antibody
Trang 1Balanced expression of single subunits in a multisubunit protein, achieved by cell fusion of individual transfectants
Lars Norderhaug1, Finn-Eirik Johansen2and Inger Sandlie3
1
Antibody Design AS, Nesoddtangen, Norway;2Department of Pathology, Rikshospitalet, Norway;3Department of Biology, University of Oslo, Norway
To establish stable cell lines that produce recombinant
multisubunit proteins, it is usually necessary to cotransfect
cells with several independent gene constructs Here, we
show that a stepwise fusion of individually transfected cells,
results in a fused cell-line that secretes a complete
multi-subunit protein Functional expression of recombinant
multisubunit proteins may require a defined expression ratio
between each protein subunit The cell-fusion technology
described allows a predefined expression level of each
sub-unit Using SIgA as a model protein we demonstrate that the
majority of the fused cells inherit the molar expression ratio
of the parental transfected cells These results indicate that simplified screening of clones expressing the expected sub-unit ratios may be possible using the cell-fusion technology This technology may therefore be an alternative to generic transfection methods for the establishment of cells that produce multiprotein complexes such as antibodies, recep-tors, ion channels and other multisubunit proteins Keywords: antibody; expression; fusion; SIgA; transfection
To establish stable cell lines that produce recombinant
multisubunit proteins, it is generally necessary to introduce
vectors that direct the expression of each subunit gene For
multisubunit proteins such as secretory antibodies [1,2],
receptors [3,4] and ion channels [5–8], a defined expression of
each unit may be essential for the specific function of the
mature protein product This is usually achieved by
cotrans-fecting cells with several independent constructs or by
introducing a single vector harbouring several discrete
expression cassettes Controlled expressions of several
poly-peptides within one cell have also been addressed using
different vector designs such as; multicistronic vectors where
each gene are controlled by internal ribosome entry site
(IRES) [9–11], panel of vectors [12] and multiple episomal
vectors [13] We chose secretory IgA (SIgA) as a model
protein to investigate the potential of cell-fusion technology
for the expression of multisubunit proteins SIgA is the major
immunoglobulin of external secretions and is composed of
four different polypeptide chains produced by two distinct
cells Polymeric IgA (pIgA) is produced by B-cells after
assembly of light-, a- and joining (J)-chain [14] SIgA is
subsequently generated when a secretory component (SC)
is covalently added to pIgA during transport across the
epithelial cells lining mucosal surfaces [15] Expression of the
multisubunit SIgA has previously been described using other
transfection methods [2,16–18] Although the principle of
cell-fusion is well established by hybridoma technology [19],
the development and application of this technology for
production of recombinant multisubunit proteins has not been described previously Here, we achieve multigene expression by utilizing cell-fusion of individually transfected cells, each expressing one or more genes that encode the multisubunit protein We show that the majority of clones resulting from the fusion inherit the expression levels of the parental cells, thus simplifying screening for clones with stochiometric expression levels of each component that secrete fully functional SIgA Furthermore, we show that this system enables high-level expression in mammalian cells, which is often a goal in recombinant protein expression
M A T E R I A L A N D M E T H O D S
Vectors and cloning of genes Construction of the vector family pLNO and its use for transfection and expression of immunoglobulin genes has been described previously [20–22] The human Ig a1 gene was subcloned into pLNO/Neo giving the vector pLNOA1/Neo The Ig heavy-chain variable-gene (VH) SS-269VH[23], specific for the outer membrane protein of the bacteria Neisseria meningitides, was subcloned into pLNOA1/Neo giving pLNOA1/Neo-SS269 The human
Ig k gene was subcloned into pLNO/Neo, giving pLNOL/ Neo The Ig light-chain variable-gene (VL) SS-269VL [23], specific for the outer membrane protein of the bacteria
N meningitides, was subcloned into pLNOL/Neo giving pLNOL/Neo-SS269 The construction of the human J-chain vector pCH (CMV-driven expression, hygromy-cin B resistance) [2] and the human SC vector pcDNA(zeo)-His6(CMV-driven expression, Zeocin resistance) has been previously described [2]
Cell culture and transfection CHO-K1 cells were obtained from ATCC (USA) and cultured in HAM F-12 (F-12 derived from hamster) with
1 m -glutamine supplemented with 10% fetal bovine
Correspondence to L Norderhaug, Antibody Design AS, P.O.Box190,
N-1450 Nesoddtangen, Norway.
Fax: + 47 66960691, Tel.: + 47 66960690,
E-mail: lars.norderhaug@antibodydesign.com
Abbreviations: IRES, internal ribosome entry site; SIgA, secretory IgA;
pIgA, polymeric IgA; J-chain, joining chain; SC, secretory component;
FITC, fluorescein isothiocyanate; HRP, horseradish peroxidase.
(Received 14 December 2001, revised 17 April 2002,
accepted 14 May 2002)
Trang 2serum All transfections were performed by electroporation
with a BTX ECM-600 electroporator (San Diego, CA,
USA) with the settings 200 V (500 VÆcm)1), 800 lF and
185 Ohm All transfections were performed in 0.4 mm
cuvettes with 20 lg of plasmid DNA and 1· 107cells per
mL in 0.8 mL NaCl/Pi at 0C giving a 12-ms pulse
Following transfection, the cells were subsequently
trans-ferred into 25 mL Dulbecco’s modified Eagle’s medium
(DMEM) or HAM F-12 with 10% fetal bovine serum in
25 cm2 flasks, and allowed to recover for 24 h before
addition of appropriate antibiotics; 800 lgÆmL)1 G418
(Invitrogen BV, the Netherlands) or 400 lgÆmL)1
hygromy-cin (Invitrogen BV, the Netherlands) or 400 lgÆmL)1Zeocin
(Invitrogen BV, the Netherlands) Three individual
transfec-tions were employed: (a) the vector pCH/J-chain/Hygro
(J-chain vector) (b) the vector pcDNA (zeo)his6/SC (SC vector)
and (c) cotransfection of the vectors pLNOL/Neo-SS269 (k
vector) and pLNOA1/Neo-SS269 (a1 vector) in CHO-K1
cells Cells were allowed to grow for 10 days before protein
expression was analysed
Cell fusion
Cell fusion was performed in two individual steps (Fig 1) by
mixing equal number of cells (3· 107cells) of each fusion
partner Cells were centrifuged (5–10 min, 200–400 g) and
washed once in serum free medium The cell mixture was
further spun down, and the supernatant was removed
completely The pellet was broken by gently tapping on the
bottom of the tube and placed in a 37C water-bath
Prewarmed 0.5 mL of 50% poly(ethylene glycol) 1500
(Boehringer Mannheim, Germany) was mixed with the cells
over a period of 1 min, under continuous stirring with a
pipette tip The cell/poly(ethylene glycol) solution was stirred
for another 1–2 min before further addition of 1 mL
prewarmed medium under continuous stirring for 1 min
An additional 3 mL of prewarmed medium was added the
same way The fusion mixture was then slowly mixed with
10 mL of prewarmed medium and incubated for 5 min The
cells were centrifuged, the supernatant discarded and growth
medium added to achieve a cell concentration of 5· 105
cellsÆmL)1 The cells were allowed to recover for 24 h, and
then diluted 1 : 100 in 100 mL growth medium
supplemen-ted with antibiotics to select for both parental clones The
cells were cultured with fresh medium every 3–5 days until
colonies appeared 10–14 days after the fusion Clones were
selected and analysed as described below
Detection of IgA, pIgA, and SIgA expression
and bound SC
Transfected and fused CHO-K1 cells were analysed for
production of IgA, pIgA or SIgA and IgA bound SC by
ELISA on supernatant of outgrown cultures Triplets of
100 lL supernatant of individually fused clones were
transferred in dilutions 1 : 1, 1 : 5, 1 : 25 to microtiter
plates coated with 4 lgÆmL)1 of N meningitides OMV
(a gift from T E Michaelsen, National Institute of Public
Health, Norway) Secondary antibodies used for detection
were rabbit anti-(human IgA) Ig (DAKO; 1 : 5000 dilution)
and rabbit anti-SC Ig (DAKO; 1 : 3000 dilution) and
tertiary antibody used for detection was horseradish
peroxidase (HRP)-conjugated goat anti-(rabbit IgG) Ig
(DAKO; 1 : 3000 dilution) The absorbance was read by Titertek Multiskan (ICN Flow, USA) The amount of IgA present in each supernatant was calculated relative to a standard preparation with known concentration
Verification of J-chain expression
To examine production of J-chain, transfected cells were screened by immunofluorescence staining CHO-K1 cells transfected with J-chain were cultured on micro slides Cells were fixed and permeabilized in methanol ()20 C for
4 min) The cells were then washed twice with NaCl/Piand incubated at room temperature for 20 min with 1 : 3000 diluted rabbit anti-(J-chain) Ig (P Brandtzaeg, LIIPAT, National Hospital, Norway) Cells were then washed three times with NaCl/Piand incubated for 20 min with (1 : 200) fluorescein isothiocyanate (FITC)-conjugated goat anti-(rabbit IgG) Ig (DAKO) Cells were washed as above and analysed by fluorescence microscopy
Verification of SC production Transfected and fused CHO-K1 cells were analysed for production of total SC, by a dot blot approach Triplets of
Fig 1 A schematic diagram of the fusion of cells producing individual protein units of a multisubunit protein Three transfected CHO-K1 cell lines producing either IgA, J-chain or SC, respectively, were fused in two steps; fusion I and fusion II Fusion I between cells producing IgA and J-chain resulted in clones producing pIgA Fusion II between cells producing pIgA and SC resulted in clones producing SIgA.
Trang 3supernatants from individual clones were applied in 1 : 1,
1 : 5, 1 : 25, 1 : 125 dilutions onto poly(vinylidene
difluo-ride) paper (Millipore; Sweden), preincubated for 3–5 s in
methanol, followed by 5 min incubation in dH2O and
subsequently 10 min incubation in blotting buffer The
membranes were then dried at 37C for 1 h, before
incubation in 25 mL NaCl/Pi/0.1% Tween-20 (NaCl/Pi/
Tween) with 10% skimmed milk and 1 : 1000 diluted rabbit
anti-SC Ig The membranes were then washed three times in
NaCl/Pi/Tween and incubated with HRP-conjugated goat
anti-(rabbit IgG) Ig (Bio-Rad; 1 : 3000 dilution) for another
1 h Finally, the membranes were washed three times in
NaCl/Pi/Tween before addition of substrate (Bio-Rad) for
5 min The membranes were covered with plastic film and
exposed to Kodak X-OMAT film for 15–60 s Dot blot
density was analysed byTOTALLABgel software (Phonetix,
UK) The amount of SC present in each supernatant was
calculated relative to a standard preparation with known
concentration
Western blot of IgA, pIgA and SIgA
Aliquots of 10 lL supernatant from selected clones were
analysed under nonreducing conditions on a 4–15% Tris/
HCl SDS/PAGE ReadyGel (Bio-Rad) run at 200 V for 1 h
The gel was blotted onto PVDF paper (Millipore; Sweden)
in a Bio-Rad Miniblotter for 1 h at 100 V Following the
transfer, the membranes were washed in NaCl/Pi for
5–10 min with gentle agitation, and blocked for 45 min in
NaCl/Pi/Tween with 10% skimmed milk The membrane
was washed once in NaCl/Pibefore incubation with either
1 : 5000 dilution rabbit anti-(human IgA) or 1 : 3000
dilution rabbit anti-(human SC) Ig for 1 h The membranes
were washed twice followed by incubation with 1 : 3000
dilution HRP-conjugated goat anti-(rabbit IgG) Ig
(Immun-StarTM Chemiluminescent Protein Detection
Systems, Bio-Rad) for 1 h The blot was developed as
described above and exposed to X-ray film for 1–10 min
R E S U L T S
To obtain SIgA-producing cells we first established cells that
stably expressed the individual protein subunits by
conven-tional transfection Transfection of the SC gene, the J-chain
gene and cotransfection of the a1 heavy-chain and k
light-chain genes resulted in clones that produced SC, J-light-chain or
IgA, respectively Selected clones were then subjected to two
fusions: the first between IgA and J-chain producing cells,
and the second between pIgA-producing cells from the first
fusion and SC-producing cells (Fig 1)
Generation of clones expressing IgA, J-chain or SC
To establish cells expressing IgA, CHO-K1 cells were
cotransfected with a1 and k genes using the two vectors
pLNOA1/Neo-SS269 and pLNOL/Neo-SS269
Superna-tants from 20 clones were analysed by ELISA and seven of
these were positive for IgA production One of these clones,
IgA-29, was chosen for further expansion and fusion with
J-chain producing cells The J-chain gene was transfected
into CHO-K1 cells using the vector pCH/J-chain/Hygro
Because J-chain is retained within the endoplasmic
reticu-lum and only secreted when joined to IgA or IgM, cells were
screened for J-chain-expression by immunofluorescence Cells from 6 clones were fixed and stained with an anti-(human J-chain) Ig to verify the presence of intracellular J-chain A further attempt to directly quantify the amount
of intracellular J-chain was avoided, as retention is closely linked to degradation [24,25] One clone, J-1, with high fluorescence intensity was selected for further expansion and fusion to IgA-29 The SC gene was transfected into CHO-K1 cells on the vector pcDNA(zeo)his6/SC Twenty-four clones were analysed by dot blot as described, and six of these were positive for SC production One clone, SC-4, was expanded for further fusion The clones IgA-29 (4.5 lgÆmL)1) and SC-4 (2.3 lgÆmL)1) were chosen for cell fusions because the amount of expressed protein on a molar basis is almost equal in these cells, as the Mrof IgA and SC are 160 and 80 kDa, respectively
Fusion of single transfectants to achieve SIgA-producing clones
The first fusion of IgA-producing cells (IgA-29) and J chain-producing cells (J-1) resulted in numerous G418 and hygromycin B resistant colonies The overall fusion effi-ciency was as high as 1· 10)3 Five colonies were analysed for production of IgA and J-chain by ELISA All five colonies were shown to produce both polypeptide chains One clone (pIgA-D) producing polymeric IgA was expan-ded for fusion with SC-producing cells (SC-4) This fusion was as effective as the first and resulted in numerous G418, hygromycin B and Zeocin resistant colonies Expanded clones from the second fusion expressed all four genes: k-chain and a1-chain, J-chain and SC
Expression levels and SIgA quality
To investigate the expression ratio between the introduced protein components of the fused cell, an IgA and SC expression level analysis was done Whereas SC is readily secreted without assembly with the other components, this is not the case for a1 heavy-chain and J-chain Both are retained and degraded intracellularly unless in complex with their appropriate partners Uncomplexed k light-chain shows some retention, but is also secreted as light-chain dimers [26] The parental cell IgA-29, the pIgA clone
pIgA-D, and eight SIgA clones (SIgA-1–8) were analysed by ELISA for expression levels of IgA and total SC (Fig 2A) and by dot blot for total SC (Fig 2A) The IgA expression levels varied from 0.5 to 5.2 lgÆmL)1 and total SC expression levels varied from 0.5 to 2.3 lgÆmL)1(Fig 2A) Importantly, more than 50% of the fused clones showed expression levels almost equal to the parental cells which was 4.5 lgÆmL)1for IgA and 2.3 lgÆmL)1for SC (Fig 2A) The molar expression ratio between IgA and total SC was calculated for each fused clone, and compared with the molar expression ratio of the parental cells SC-4/pIgA-D The molar ratio varied from 0.9 to 2.2, while 50% of the clones maintained the molar ratio of 1 (Fig 2B) This shows that the selection and isolation of clones expressing a stochiometric or predefined ratio of different protein subunits is well within reach of a simple screening proce-dure SC bound to IgA also correlated with IgA expression levels in all fused clones shown by ELISA (data not shown) Because SC only interacts with J-chain-positive pIgA, the
Trang 4complexing of IgA and J-chain is a prerequisite for SC
binding Therefore, the correlation between the IgA and SC
levels in all the clones demonstrated that a sufficient amount
of J-chain was available for SIgA complex formation One
SIgA-producing clone (SIgA-3) along with pIgA-D and
IgA-29 were analysed by SDS/PAGE gel and Western blot
(Fig 3) to characterize the molecular size and composition
of the secreted products This Western blot clearly
demon-strated that cells fused to produce all the four polypeptides
of SIgA, assembled and secreted SIgA of the expected
molecular size with reactivity against antibodies towards both IgA and SC The fused cells expressed both monomeric and polymeric IgA as described for hybridoma cells expressing monoclonal IgA [27], and was also seen when the J-chain gene was transfected into an IgA-producing CHO cell line [2] The production level of the fused cells grown in culture, without any selective pressure, was measured by ELISA for two months During this time period, no change in expression levels was observed The fused cells were also frozen and thawed without any change
in growth or expression rate In conclusion the fused cells behaved as their transfected parental cells with respect to morphology, growth rate and expression rate
D I S C U S S I O N
Stable transfection of mammalian cells requires that the gene of interest is integrated into the chromosome by a nonhomologous recombination event [28,29] This is a rare event and results in a very low frequency of integration and variable expression levels due to the so-called position effect [30] and the copy number of integrated genes [31–33]
It has been observed that the variation in expression levels among individual clones varies with > 30-fold in a single gene transfection assay [11,34–36] (L Norderhaug &
I Sandlie, unpublished data) Thus, to establish a single cell line expressing defined ratios of multiple protein units, excessive screening is necessary, as each gene introduced into the cell multiplies the complexity of the screening Others have addressed the problem of stochiometric expression by construction of special vectors with IRES elements that guide bicistronic or multicistronic expression [9–11,37] However, the use of IRES elements may require complex plasmid construction or be limited to the use of short cDNAs due to the size of the complete gene Stochiometric expressions by multiple episomal vectors [13,38–40] have been addressed The advantage of episomal vectors is the property of the vector to replicate extra-chromosomally, and thereby eliminate the positional effect [30] of chromosomal integrating vectors However, for stable expression of multiple genes over time, the usefulness
of such episomal vector is limited, mainly because of the slow loss of the vector over time when unselected [39] A defined expression ratio between each protein subunit may
be essential for the specific function of the mature protein product Study of ion channels [8] and receptors [3,41] have shown that their structure and functions actually depend on the level of expression of the different subunits Thus, cell-fusion technology will allow generation of cells with a
Fig 3 Western blot of assembled IgA, pIgA and SIgA SDS/PAGE and Western blot of untransfected CHO-K1 cells (lane 1), IgA-29 (lane 2), pIgA-D (lane 3 and 5) and SIgA-3 (lane 4 and 6) detected by antihuman IgA or stripped and redetected with antihuman SC, as indicated The blot shows assembly of all protein subunits in the fused cells.
Fig 2 IgA and total SCproduction levels (A) and molar expression
ratios (B) (A) IgA and SC expression levels of outgrown supernatants
of the clones: SC-4, IgA-29, pIgA-D and SIgA-1–8 measured in triplets
by ELISA or dot blot (B) Calculation of the molar expression ratio
between the subcomponents SC and IgA in each fusion clone SIgA1-8
and also between their parental cells SC-4 and IgA-29 Calculations
were based on measured expression levels of both SC and IgA (A) and
the M r of SC (80 kDa) and IgA (160 kDa).
Trang 5predefined expression level of each protein subunit and
hence predefined molar ratios The result presented here
show that the fusion event typically does not alter the
expression level of the recombinant protein (Fig 2B)
Furthermore, in the study of structure–function
relation-ships of protein complexes, individual components may be
altered by site directed mutagenesis A cell line expressing
the altered gene product at a given level may then be fused
to constitute an altered complex Cell-fusion is possible
using CHO-K1, one of the cell-lines most widely used for
recombinant protein production, and the technology is also
applicable to NS0 cells (L Norderhaug & I Sandlie,
unpublished data)
A C K N O W L E D G E M E N T S
This research was supported by Oslo Research Park AS and The
Research Council of Norway.
R E F E R E N C E S
1 Chintalacharuvu, K.R & Morrison, S.L (1997) Production of
secretory immunoglobulin A by a single mammalian cell Proc.
Natl Acad Sci USA 94, 6364–6368.
2 Johansen, F., Norderhaug, I., Roe, M., Sandlie, I & Brandtzaeg,
P (1999) Recombinant expression of polymeric IgA:
incorpora-tion of J chain and secretory component of human origin Eur J.
Immunol 29, 1701–1708.
3 Tretter, V., Hauer, B., Nusser, Z., Mihalek, R., Hoger, H.,
Homanics, G., Somogyi, P & Sieghart, W (2001) Targeted
disruption of the GABA (subA) receptor (delta) subunit gene leads
to an upregulation of (gamma) (sub2) subunit-containing
receptors in cerebellar granule cells J Biol Chem 276, 10532–
10538.
4 Sieghart, W., Fuchs, K., Tretter, V., Ebert, V., Jechlinger, M.,
Hoger, H & Adamiker, D (1999) Structure and subunit
com-position of GABA (A) receptors Neurochem Int 34, 379–385.
5 Xu, J., Yu, W., Wright, J., Raab, R & Li, M (1998) Distinct
functional stoichiometry of potassium channel beta subunits.
Proc Natl Acad Sci USA 95, 1846–1851.
6 Tucker, S., Pessia, M & Adelman, J (1996) Muscarine-gated K+
channel: subunit stoichiometry and structural domains essential
for G protein stimulation Am J Physiol 271, H379–H385.
7 Inagaki, N., Gonoi, T & Seino, S (1997) Subunit stoichiometry of
the pancreatic beta-cell ATP-sensitive K+ channel FEBS Lett.
409, 232–236.
8 Manganas, L & Trimmer, J (2000) Subunit composition
determines Kv1 potassium channel surface expression J Biol.
Chem 275, 29685–29693.
9 Zhu, J., Musco, M & Grace, M (1999) Three-color flow
cyto-metry analysis of tricistronic expression of eBFP, eGFP, and
eYFP using EMCV-IRES linkages Cytometry 37, 51–59.
10 Gurtu, V., Yan, G & Zhang, G (1996) IRES bicistronic
expres-sion vectors for efficient creation of stable mammalian cell lines.
Biochem Biophys Res Commun 229, 295–298.
11 Liu, X., Constantinescu, S., Sun, Y., Bogan, J., Hirsch, D.,
Weinberg, R & Lodish, H (2000) Generation of mammalian cells
stably expressing multiple genes at predetermined levels Anal.
Biochem 280, 20–28.
12 Cockett, M., Ochalski, R., Benwell, K., Franco, R &
Wardwell-Swanson, J (1997) Simultaneous expression of multi-subunit
proteins in mammalian cells using a convenient set of mammalian
cell expression vectors Biotechniques 23, 406–407.
13 Horlick, R., Schilling, A., Samama, P., Swanson, R., Fitzpatrick,
V., Robbins, A & Damaj, B (2000) Combinatorial gene
expres-sion using multiple episomal vectors Gene 243, 187–194.
14 Johansen, F., Braathen, R & Brandtzaeg, P (2000) Role of J chain in secretory immunoglobulin formation Scand J Immunol.
52, 240–248.
15 Norderhaug, I., Johansen, F., Schjerven, H & Brandtzaeg, P (1999) Regulation of the formation and external transport of secretory immunoglobulins Crit Rev Immunol 19, 481–508.
16 Chintalacharuvu, K.R & Morrison, S.L (1999) Production and characterization of recombinant IgA Immunotechnology 4, 165– 174.
17 Frigerio, L., Vine, N., Pedrazzini, E., Hein, M., Wang, F., Ma, J.
& Vitale, A (2000) Assembly, secretion, and vacuolar delivery of a hybrid immunoglobulin in plants Plant Physiol 123, 1483–1494.
18 Ma, J., Hiatt, A., Hein, M., Vine, N., Wang, F., van Stabila, P.D.C., Mostov, K & Lehner, T (1995) Generation and assembly
of secretory antibodies in plants Science 268, 716–719.
19 Kohler, G & Milstein, C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity Nature 256, 495–497.
20 Sorensen, V., Rasmussen, I., Norderhaug, L., Natvig, I., Michaelsen, T & Sandlie, I (1996) Effect of the IgM and IgA secretory tailpieces on polymerization and secretion of IgM and IgG J Immunol 156, 2858–2865.
21 Norderhaug, L., Olafsen, T., Michaelsen, T.E & Sandlie, I (1997) Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells J Immunol Methods 204, 77–87.
22 Olafsen, T., Rasmussen, I.B., Norderhaug, L., Bruland, O.S & Sandlie, I (1998) IgM secretory tailpiece drives multimerisation of bivalent scFv fragments in eukaryotic cells Immunotechnology 4, 141–153.
23 Wang, J., Jarvis, G.A., Achtman, M., Rosenqvist, E., Michaelsen, T.E., Aase, A & Griffiss, J.M (2000) Functional activities and immunoglobulin variable regions of human and Infect Immun.
68, 1871–1878.
24 Klausner, R & Sitia, R (1990) Protein degradation in the endoplasmic reticulum Cell 62, 611–614.
25 Mancini, R., Fagioli, C., Fra, A., Maggioni, C & Sitia, R (2000) Degradation of unassembled soluble Ig subunits by cytosolic proteasomes: evidence that retrotranslocation and degradation are coupled events FASEB J 14, 769–778.
26 Reddy, P., Sparvoli, A., Fagioli, C., Fassina, G & Sitia, R (1996) Formation of reversible disulfide bonds with the protein matrix of the endoplasmic reticulum correlates with the retention of unassembled Ig light chains EMBO J 15, 2077–2085.
27 Stoll, T., Chappaz, A., von Stockar, U & Marison, I (1997) Effects of culture conditions on the production and quality
of monoclonal IgA In Enzyme and Microbial Technology, pp 203–211.
28 Roth, D.B., Porter, T.N & Wilson, J.H (1985) Mechanisms of nonhomologous recombination in mammalian cells Mol Cell Biol 5, 2599–2607.
29 Roth, D.B & Wilson, J.H (1986) Nonhomologous recombina-tion in mammalian cells: role for short sequence homologies in the joining reaction Mol Cell Biol 6, 4295–4304.
30 Wilson, C., Bellen, H & Gehring, W (1990) Position effects on eukaryotic gene expression Annu Rev Cell Biol 6, 679–714.
31 Zastrow, G., Koehler, U., Muller, F., Klavinius, A., Wegner, M., Wienberg, J., Weidle, U.H & Grummt, F (1989) Distinct mouse DNA sequences enable establishment and persistence of plasmid DNA polymers in mouse cells Nucleic Acids Res 17, 1867–1879.
32 Pulm, W & Knippers, R (1985) Transfection of mouse fibroblast cells with a promoterless herpes simplex virus thymidine kinase gene: number of integrated gene copies and structure of single and amplified gene sequences Mol Cell Biol 5, 295–304.
33 Hemann, C., Gartner, E., Weidle, U.H & Grummt, F (1994) High-copy expression vector based on amplification-promoting sequences DNA Cell Biol 13, 437–445.
Trang 634 Bebbington, C.R., Renner, G., Thomson, S., King, D., Abrams,
D & Yarranton, G.T (1992) High-level expression of a
recombinant antibody from myeloma cells using a glutamine
synthetase gene as an amplifiable selectable marker Biotechnology
10, 169–175.
35 Hendricks, M.B., Banker, M.J & McLaughlin, M (1988) A
high-efficiency vector for expression of foreign genes in myeloma cells.
Gene 64, 43–51.
36 Wurm, F.M., Johnson, A., Ryll, T., Ko¨hne, C., Scherthan, H.,
Glaab, F., Lie, Y.S., Petropoulos, C.J & Arathoon, W.R (1996)
Gene transfer and amplification in CHO cells Efficient methods
for maximizing specific productivity and assessment of genetic
consequences Ann NY Acad Sci 782, 70–78.
37 Martinez-Salas, E (1999) Internal ribosome entry site biology and its use in expression vectors Curr Opin Biotechnol 10, 458–464.
38 Van, C.K., Vanhoenacker, P., Duchau, H & Haegeman, G (2000) Molecular integrity and usefulness of episomal expression vectors derived from BK and Epstein–Barr virus Gene 253, 293–301.
39 Vanhoenacker, P & Haegeman, G (2000) Episomal vectors for gene expression in mammalian cells Eur J Biochem 267, 5665– 5678.
40 Mizuguchi, H., Hosono, T & Hayakawa, T (2000) Long-term replication of Epstein–Barr virus-derived episomal vectors in the rodent cells FEBS Lett 472, 173–178.
41 Eertmoed, A., Vallejo, Y & Green, W (1998) Transient expression
of heteromeric ion channels Methods Enzymol 293, 564–585.